100s of titles, one news app for just $10 a month.
Dive Deeper:
Orchard Therapeutics: Q1 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Earnings Preview: Regulus Therapeutics
Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Onconova Therapeutics Earnings Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Preview: Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Preview: Lineage Cell Therapeutics
Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need…
Synlogic Earnings Preview
Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know…
Get all your news in one place
Latest Business news:
Bill Gates reveals why he doesn’t own cryptocurrency
Cryptocurrencies have seen around $1 trillion wiped off their value in 2022
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
Hedge Fund Up 138% This Year Is Turning Bullish on China Stocks
A fund manager who made triple-digit gains by hedging risks in Chinese equities is now turning bullish on mainland shares.
Apple Analyst Hints At Imminent Launch Of Next Iteration Of This Key Product
Apple, Inc. (NASDAQ: AAPL) is expected to have a strong launch year in 2022.
Tesla Drops To Number 2: Is Cathie Wood's Ark Invest Losing Confidence In Its Favorite Stock?
Tesla, Inc. (NASDAQ: TSLA) stock has been going downhill since peaking in early November 2021.
Survivor, Bachelor in Paradise, Love Island: How Fiji is cashing in on reality TV favourites
Fiji is a small nation looking for big investment and it is working hard to make film and reality television…
From analysis to good news, read the world’s best news in one place
What do Elon Musk and Jeff Bezos have in common? An unhealthy Twitter habit
They are two of the world’s richest people, and both are obsessed with space travel, but they use social media…
The Stats Guy: What does tourism in Australia look like now that travellers are returning?
The tourism sector is preparing for a comeback. So, what is the state of play in the sector and what…

Orchard Therapeutics Earnings Preview

By Benzinga Insights

Orchard Therapeutics (NASDAQ:ORTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know before the announcement.

Analysts estimate that Orchard Therapeutics will report an earnings per share (EPS) of $-0.26.

Orchard Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.01, which was followed by a 3.78% drop in the share price the next day.

Here's a look at Orchard Therapeutics's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate -0.28 -0.25 -0.33 -0.32
EPS Actual -0.29 -0.29 -0.29 -0.31
Price Change % -3.78% 0.54% 3.1% 9.0%

Stock Performance

Shares of Orchard Therapeutics were trading at $0.4491 as of May 10. Over the last 52-week period, shares are down 91.0%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.

To track all earnings releases for Orchard Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Orchard Therapeutics: Q1 Earnings Insights
Orchard Therapeutics (NASDAQ:ORTX) reported its Q1 earnings results on Thursday, May 12, 2022 at 07:00 AM. Here's what investors need…
Earnings Preview: Regulus Therapeutics
Regulus Therapeutics (NASDAQ:RGLS) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
Onconova Therapeutics Earnings Preview
Onconova Therapeutics (NASDAQ:ONTX) is set to give its latest quarterly earnings report on Wednesday, 2022-05-11. Here's what investors need to…
Preview: Virios Therapeutics's Earnings
Virios Therapeutics (NASDAQ:VIRI) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Preview: Lineage Cell Therapeutics
Lineage Cell Therapeutics (AMEX:LCTX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need…
Synlogic Earnings Preview
Synlogic (NASDAQ:SYBX) is set to give its latest quarterly earnings report on Thursday, 2022-05-12. Here's what investors need to know…
Get all your news in one place